drugset / Trial / NCT07812701

Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis

NCT07812701 ↗

Phase 2 Not yet recruiting 187 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, comparative trial evaluating the efficacy on pain intensity between topical Clobetasol Propionate 0.05% and placebo in patients with symptomatic hand osteoarthritis.

Timeline

Start
2026-09
Primary completion
2026-11
Completion
2027-11

Drugs

EvaluationDrugModalityDoseRoute
Subject clobetasol propionate Small molecule 0.05 % Topical

Indications